AB International Health Care Portfolio

Portugal

Institutional Investor
Investidor Profissional (English)
Investidor Particular
The Portugal website is not available. You will be redirected to the Luxembourg website which contains funds approved for marketing in Luxembourg, and where several of these funds are not registered for marketing in Portugal.

O sítio Web de Portugal não está disponível. Será redireccionado para o sítio do Luxemburgo, que contém fundos aprovados para comercialização no Luxemburgo, e onde vários desses fundos não estão registados para comercialização em Portugal.

Investing in Business – not Science

We believe innovation and cost reduction within the healthcare sector are creating opportunities for the best companies to gain share and generate strong returns. Through our disciplined investment process, we focus on profitability and reinvestment to access return potential.

Focus on business not science

Rather than trying to predict scientific outcomes, we use in-depth research and analysis to invest in businesses that aim to provide better outcomes, help to drive cost savings and generate profits.

High quality business

Through continuous collaboration between managers and analysts, we select between 40-60 stocks, investing in what we believe to be the very best businesses. We look for capital efficiency and strong reinvestment rates to achieve quality compounding.

Risk management

The healthcare sector has defensive characteristics and is less exposed to the macro environment. Portfolio risk is balanced around multiple companies, as opposed to only a few stocks delivering extreme individual performance.

The value of an investment can go down as well as up and investors may not get back the full amount they invested. Capital is at risk.

An Experienced Team

Our portfolio managers are supported by a dedicated team of analysts and researchers offering deep experience and global perspectives.

Vinay Thapar, CFA

13 Years at AB

25 Years of Experience

John H. Fogarty, CFA

30 Years at AB

32 Years of Experience

Pricing & Performance

Annualised Performance
Calendar Year Performance
Complete 12 Month Returns
Growth of Investment
Daily Data

Past performance does not guarantee future results.

The Fund is not managed to target or exceed the performance of any specific benchmark, nor are investment decisions constrained by any benchmark. However, investors can assess the performance of the Fund against index shown.

The display above shows the performance based on total return net of management fees, but does not reflect sales charges or the effect of taxes. The figures therefore do not reflect the actual return to an investor.

The charges paid by the Fund are used to pay the costs for running the Fund, including the costs of marketing and distributing it. These charges reduce the potential return of your investment. For a complete description and full details of the applicable costs and charges, please refer to the Fund’s Prospectus.

The Management Fee is an annual fee paid to the management company to which the management of the Fund has been delegated. Out of this fee, the management company pays the investment management fee to the Investment Manager but also may pay other service providers.

The Performance Fee (if any) is paid to the Investment Manager under certain specific conditions.

The Ongoing Charges are charges taken from the Fund over a year based on expenses for the year. This figure may vary from year to year. It excludes performance fees (if any), portfolio transaction costs, except in the case of an entry/exit charge paid by the Fund, when buying or selling units in another collective investment undertaking. The Ongoing Charges figure can help you compare the annual operating expenses of different funds.

The Entry and Exit Charges shown are maximum figures and are one-off charges taken before or after you invest in the Fund.

Complete Portfolio of Holdings

Holdings are subject to change without notice.

Investment Risks to Consider

These and other risks are described in the Portfolio's prospectus

Investment in the Portfolio entails certain risks. Investment returns and principal value of the Portfolio will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Some of the principal risks of investing in the Portfolio include:

Allocation risk: The risk that the allocation of investments between growth and value companies may have a more significant effect on the Portfolio’s Net Asset Value (NAV) when one of these strategies is not performing as well as the other. In addition, the transaction costs of rebalancing the investments may, over time, be significant.
Derivatives risk: The Portfolio may include financial derivative instruments. These may be used to obtain, increase or reduce exposure to underlying assets and may create gearing; their use may result in greater fluctuations of the net asset value.
Emerging-markets risk: Where the Portfolio invests in emerging markets, these assets are generally smaller and more sensitive to economic and political factors, and may be less easily traded, which could cause a loss to the Portfolio.
Equity securities risk: The value of equity investments may fluctuate in response to the activities and results of individual companies or because of market and economic conditions. These investments may decline over short- or long-term periods.
Focused portfolio risk: Investing in a limited number of issuers, industries, sectors or countries may subject the Portfolio to greater volatility than one invested in a larger or more diverse array of securities.
OTC derivatives counterparty risk: Transactions in over-the-counter (OTC) derivatives markets may have generally less governmental regulation and supervision than transactions entered into on organized exchanges. These will be subject to the risk that its direct counterparty will not perform its obligations and that the Portfolio will sustain losses.
Portfolio turnover risk: A portfolio may be actively managed and turnover may, in response to market conditions, exceed 100%. A higher rate of portfolio turnover increases brokerage and other expenses. High portfolio turnover may also result in the realization of substantial net short-term capital gains, which may be taxable when distributed.

Fund Literature

This is a marketing communication. This information is provided by AllianceBernstein (Luxembourg) S.à r.l. Société à responsabilité limitée, R.C.S. Luxembourg B 34 305, 2-4, rue Eugène Ruppert, L-2453 Luxembourg. Authorised in Luxembourg and regulated by the Commission de Surveillance du Secteur Financier (CSSF). It is provided for informational purposes only and does not constitute investment advice or an invitation to purchase any security or other investment. The views and opinions expressed are based on our internal forecasts and should not be relied upon as an indication of future market performance. The value of investments in any of the Funds can go down as well as up and investors may not get back the full amount invested. Past performance does not guarantee future results.

This information is directed at Professional Clients only and is not intended for public use.